Upgrade to SI Premium - Free Trial

Jefferies Starts Compass Pathways (CMPS) at Buy

May 4, 2026 2:12 AM
Jefferies analyst Andrew Tsai initiates coverage on Compass Pathways (NASDAQ: CMPS) with a Buy rating and a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage